Harry Vennema

Harry Vennema

Auto-generated profile, based on publicly available information

Harry Vennema

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of General Virology
Verified
Journal Article
Open access
PCPreeti Chhabra
Preeti Chhabra
MGMiranda de Graaf
Miranda de Graaf
GPGabriel Parra
Gabriel Parra
MCMartin Chi-Wai Chan
Martin Chi-Wai Chan
KGKim Green
Kim Green
JVJan Vinjé
Jan Vinjé
Noroviruses are genetically diverse RNA viruses associated with acute gastroenteritis in mammalian hosts. Phylogenetically, they can be segregated into different genogroups as well as P (polymerase)-groups and further into genotypes and P-types based on amino acid diversity of the complete VP1 gene and nucleotide diversity of the RNA-dependent RNA polymerase (RdRp) region of ORF1, respectively. In recent years, several new noroviruses have been reported that warrant an update of the existing classification scheme. Using previously described 2× standard deviation (sd) criteria to group sequences into separate clusters, we expanded the number of genogroups to 10 (GI-GX) and the number of genotypes to 49 (9 GI, 27 GII, 3 GIII, 2 GIV, 2 GV, 2 GVI and 1 genotype each for GVII, GVIII, GIX [formerly GII.15] and GX). Viruses for which currently only one sequence is available in public databases were classified into tentative new genogroups (GNA1 and GNA2) and genotypes (GII.NA1, GII.NA2 and GIV.NA1) with their definitive assignment awaiting additional related sequences. Based on nucleotide diversity in the RdRp region, noroviruses can be divided into 60 P-types (14 GI, 37 GII, 2 GIII, 1 GIV, 2 GV, 2 GVI, 1 GVII and 1 GX), 2 tentative P-groups and 14 tentative P-types. Future classification and nomenclature updates will be based on complete genome sequences and will be coordinated and disseminated by the international norovirus classification-working group.

7 March 2019 in Eurosurveillance
Verified
Journal Article
Open access
AMAnnemieke Christine Mulder
Annemieke Christine Mulder
AKAnnelies Kroneman
Annelies Kroneman
EFEelco Franz
Eelco Franz
HVHarry Vennema
Harry Vennema
ATAnna D. Tulen
Anna D. Tulen
Elisabetta SuffrediniElisabetta Suffredini
Elisabetta Suffredini
Hepatitis E virus (HEV) is a common cause of acute hepatitis worldwide. In Europe, HEV is a zoonosis transmitted via contaminated pork meat or other pork food products. Genotype 3 is the most prevalent HEV type in the animal reservoir, as well as in humans. Despite an increased incidence of hepatitis E across Europe, much remains unknown about its spread, sources and transmission routes. A One Health approach is crucial to better understand the (molecular) epidemiology of HEV. HEVnet was established in April 2017 as a network and database for sharing sequences and accompanying metadata collected from human, animal, food and environmental sources. HEVnet members working in the public health, veterinary health, food, environmental and blood safety sectors have submitted 1,615 HEV sequences from nine countries as at January 2019. Most are from humans (89%), and sequences of animal (5%), food (6%) or environmental (0.3%) origin are rare. Metadata for human sequences capture mostly sex (93%), year of birth (92%) and sampling (100%); data on region of sampling (37%) and clinical information (hospitalisation 27%, symptoms 20% or mortality 8%) are limited. HEVnet aims to expand into a global network capable of performing cross-sectoral and supranational studies, with a joint repository of molecular and epidemiological data on HEV.

22 February 2023 in Science Translational Medicine
Verified
Journal Article
Open access
SAStijn P. Andeweg
Stijn P. Andeweg
HVHarry Vennema
Harry Vennema
IVIrene Veldhuijzen
Irene Veldhuijzen
NSNaomi Smorenburg
Naomi Smorenburg
DSDennis Schmitz
Dennis Schmitz
RGRIVM COVID-19 Molecular epidemiology group‡
RIVM COVID-19 Molecular epidemiology group‡
The extent to which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) break through infection- or vaccine-induced immunity is not well understood. We analyzed 28,578 sequenced SARS-CoV-2 samples from individuals with known immune status obtained through national community testing in the Netherlands from March to August 2021. We found evidence of an increased risk of infection by the Beta (B.1.351), Gamma (P.1), or Delta (B.1.617.2) variants compared with the Alpha (B.1.1.7) variant after vaccination. No clear differences were found between vaccines. However, the effect was larger in the first 14 to 59 days after complete vaccination compared with ≥60 days. In contrast to vaccine-induced immunity, there was no increased risk for reinfection with Beta, Gamma, or Delta variants relative to the Alpha variant in individuals with infection-induced immunity.

7 June 2018 in Eurosurveillance
Verified
Journal Article
Open access
IFIngrid Friesema
Ingrid Friesema
GSGerard Jb Sonder
Gerard Jb Sonder
MPMariska Wf Petrignani
Mariska Wf Petrignani
AMAnnemarie E Meiberg
Annemarie E Meiberg
GRGini Gc van Rijckevorsel
Gini Gc van Rijckevorsel
HVHarry Vennema
Harry Vennema
Since 2015, outbreaks of hepatitis A among men who have sex with men (MSM) have been reported worldwide. To examine the impact of these MSM outbreaks in the Netherlands, we combined notification and epidemiological data with sequence analysis. Our results show the hazards of outbreaks within risk-groups spilling over into the largely susceptible general population. One third of the outbreak-related hepatitis A virus genotypes were detected in non-MSM cases.

21 January 2016 in Eurosurveillance
Verified
Journal Article
Open access
IBIngeborg Boxman
Ingeborg Boxman
LVLinda Verhoef
Linda Verhoef
HVHarry Vennema
Harry Vennema
SNSiew-Lin Ngui
Siew-Lin Ngui
IFIngrid Friesema
Ingrid Friesema
MKMarion P.G. Koopmans
Marion P.G. Koopmans
This report describes an outbreak investigation starting with two closely related suspected food-borne clusters of Dutch hepatitis A cases, nine primary cases in total, with an unknown source in the Netherlands. The hepatitis A virus (HAV) genotype IA sequences of both clusters were highly similar (459/460 nt) and were not reported earlier. Food questionnaires and a case–control study revealed an association with consumption of mussels. Analysis of mussel supply chains identified the most likely production area. International enquiries led to identification of a cluster of patients near this production area with identical HAV sequences with onsets predating the first Dutch cluster of cases. The most likely source for this cluster was a case who returned from an endemic area in Central America, and a subsequent household cluster from which treated domestic sewage was discharged into the suspected mussel production area. Notably, mussels from this area were also consumed by a separate case in the United Kingdom sharing an identical strain with the second Dutch cluster. In conclusion, a small number of patients in a non-endemic area led to geographically dispersed hepatitis A outbreaks with food as vehicle. This link would have gone unnoticed without sequence analyses and international collaboration.

30 October 2008 in Eurosurveillance
Verified
Journal Article
Open access
LVL Verhoef
L Verhoef
EDE Duizer
E Duizer
HVH Vennema
H Vennema
JSJ Siebenga
J Siebenga
CSCorien M Swaan
Corien M Swaan
GDG Delmas
G Delmas
Between mid-September and 19 October 2008, nine clusters of norovirus infection involving around 90 primary cases and over a hundred secondary cases were identified in patients from the Netherlands, Ireland, Italy and France, linked to pilgrimage to Lourdes, France.